Cameron DA - Search Results

1

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL. Goss PE, et al. Among authors: cameron da. J Natl Cancer Inst. 2005 Sep 7;97(17):1262-71. doi: 10.1093/jnci/dji250. J Natl Cancer Inst. 2005. PMID: 16145047 Free article. Clinical Trial.

2

Continuous 5-fluorouracil in the treatment of breast cancer.

Cameron DA, Gabra H, Leonard RC. Cameron DA, et al. Br J Cancer. 1994 Jul;70(1):120-4. doi: 10.1038/bjc.1994.259. Br J Cancer. 1994. PMID: 8018521 Free PMC article. Review.

3

The case for high-dose adjuvant chemotherapy in breast cancer: (I) theoretical considerations.

Cameron DA, Leonard RC. Cameron DA, et al. Eur J Surg Oncol. 1996 Oct;22(5):540-2. doi: 10.1016/s0748-7983(96)93201-1. Eur J Surg Oncol. 1996. PMID: 8903501

4

The case for high-dose adjuvant chemotherapy in breast cancer: (II) clinical experience.

Cameron DA, Leonard RC. Cameron DA, et al. Eur J Surg Oncol. 1996 Dec;22(6):634-7. doi: 10.1016/s0748-7983(96)92528-7. Eur J Surg Oncol. 1996. PMID: 9005153 Review.

5

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.

Cameron DA, Anderson ED, Levack P, Hawkins RA, Anderson TJ, Leonard RC, Forrest AP, Chetty U. Cameron DA, et al. Br J Cancer. 1997;76(8):1099-105. doi: 10.1038/bjc.1997.514. Br J Cancer. 1997. PMID: 9376273 Free PMC article. Clinical Trial.

6

Re: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.

Cameron DA, Leonard RC. Cameron DA, et al. J Natl Cancer Inst. 1999 Apr 21;91(8):728-9. doi: 10.1093/jnci/91.8.728. J Natl Cancer Inst. 1999. PMID: 10218517 No abstract available.

7

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.

Cameron DA, Gregory WM, Bowman A, Anderson ED, Levack P, Forouhi P, Leonard RC. Cameron DA, et al. Br J Cancer. 2000 Jul;83(1):98-103. doi: 10.1054/bjoc.2000.1216. Br J Cancer. 2000. PMID: 10883676 Free PMC article.

8

Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study.

Cameron DA, Cornbleet MC, Mackie RM, Hunter JA, Gore M, Hancock B, Smyth JF; Scottish Melanoma Group. Cameron DA, et al. Br J Cancer. 2001 May 4;84(9):1146-9. doi: 10.1054/bjoc.2000.1623. Br J Cancer. 2001. PMID: 11379605 Free PMC article. Clinical Trial.

9

Letrozole as primary medical therapy for locally advanced and large operable breast cancer.

Dixon JM, Love CD, Bellamy CO, Cameron DA, Leonard RC, Smith H, Miller WR. Dixon JM, et al. Among authors: cameron da. Breast Cancer Res Treat. 2001 Apr;66(3):191-9. doi: 10.1023/a:1010669403283. Breast Cancer Res Treat. 2001. PMID: 11510690 Clinical Trial.

10

Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

Cameron DA, Anderson A, Toy E, Evans TR, Le Vay JH, Kennedy IC, Grieve RJ, Perren TJ, Jones A, Mansi J, Crown J, Leonard RC. Cameron DA, et al. Br J Cancer. 2002 Dec 2;87(12):1365-9. doi: 10.1038/sj.bjc.6600660. Br J Cancer. 2002. PMID: 12454763 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page